Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Volumn 19 Suppl 2, Issue , 2009, Pages

  Friedlander, Michael ^a   Butow, Phyllis ^a   Stockler, Martin ^a   Gainford, Corona ^a   Martyn, Julie ^a   Oza, Amit ^a   Donovan, Heidi S ^a   Miller, Brigitte ^a   King, Madeline ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; BIOLOGICAL MODEL; CARCINOMA; DRUG RESISTANCE; EVALUATION; FEMALE; HUMAN; METHODOLOGY; OVARY TUMOR; PALLIATIVE THERAPY; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; PALLIATIVE CARE; PLATINUM COMPOUNDS; RECURRENCE;

MLCS; MLOWN;

EID: 77950366586     PISSN: None     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/igc.0b013e3181bf7fb8     Document Type: Review

References (19)